Gilead’s twice-yearly shot to prevent HIV succeeds in late-stage trial, found 100% effective
Gilead’s twice-yearly shot to prevent HIV succeeds in late-stage trial, found 100% effective
www.cnbc.com Gilead’s twice-yearly shot to prevent HIV succeeds in late-stage trial
Gilead's experimental twice-yearly medicine to prevent HIV was 100% effective in a late-stage trial, the company said Thursday.
2
comments
Unfortunate corporate name.
Under His Eye